EVERYTHING ABOUT API IN PHARMACEUTICAL MANUFACTURING

“The present scenario has exposed some structural weaknesses inside the EU’s medicines source chain plus a large dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides claimed. She encouraged that supply chain issues be dealt with in an EU pharmaceutical system envisioned to get introduced by the tip of your calendar